pharmadog: fetch the data, sniff the signal

Week of Nov 9, 2026

RECRUITINGphase readout6dTrial primary completion: Acceptability and Tolerance Study of Bolus Tube Feed With Food Blends

Sponsor: Société des Produits Nestlé (SPN). Status: Recruiting. Conditions: Cerebral Palsy (CP), Oncology. NCT07341464.

full page →ctgov ↗

NOT_YET_RECRUITINGphase readout6dTrial primary completion: FIFA 11+ in Young Female Volleyball Players

Sponsor: Acibadem University. Status: Not yet recruiting. Conditions: Sport Injuries. NCT07733648.

full page →ctgov ↗

RECRUITINGphase readout6dTrial primary completion: GRID Therapy for Extremity Soft Tissue Sarcoma

Sponsor: UNC Lineberger Comprehensive Cancer Center. Status: Recruiting. Conditions: Sarcoma. NCT06073067.

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readout6dTrial primary completion: Differential Effects of Aerobic and Circuit Training on Glycemic Regulation in Diabetic Children

Sponsor: Emad Eldin Mohamed. Status: Active, not recruiting. Conditions: Diabetic Children. NCT07874854.

full page →ctgov ↗

RECRUITINGphase readout6dPhase 4 primary completion: Vitamin D2 vs Vitamin D2 Plus Calcitriol in Cholestatic Children With Vitamin D Deficiency

Sponsor: Chulalongkorn University. Status: Recruiting. Conditions: Cholestatic Liver Disease, Chronic Liver Disease (CLD), Vitamin D Deficiency, Children. NCT07670611.

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readout7dPhase 3 primary completion: Trastuzumab Deruxtecan (T-DXd) With or Without Pertuzumab Versus Taxane, Trastuzumab and Pertuzumab in HER2-positive Metastatic Breast Cancer (DESTINY-Breast09)

Sponsor: AstraZeneca. Status: Active, not recruiting. Conditions: Breast Cancer; HER2-positive; Metastatic. NCT04784715.

full page →ctgov ↗

RECRUITINGphase readout7dPhase 2 primary completion: EUS Guided Portal-systemic Pressure Gradient Measurement

Sponsor: Chinese University of Hong Kong. Status: Recruiting. Conditions: Portal Hypertension, Cirrhosis. NCT04633356.

full page →ctgov ↗

RECRUITINGphase readout7dTrial primary completion: Ursodeoxycholic Acid Attenuates Statin-Induced Impaired Glucose Tolerance

Sponsor: First Affiliated Hospital Xi'an Jiaotong University. Status: Recruiting. Conditions: Hyperlipidemia, Ursodeoxycholic Acid, Statin Therapy, Glucose Intolerance. NCT06684106.

full page →ctgov ↗

NOT_YET_RECRUITINGphase readout8dTrial primary completion: Comparative Effectiveness of Yakson Touch and a Dextrose-Sweetened Pacifier for Reducing Phlebotomy-Induced Pain in Term Neonates

Sponsor: RAK Medical and Health Sciences University. Status: Not yet recruiting. Conditions: Hospital Acquired Infections. NCT07788066.

full page →ctgov ↗

RECRUITINGphase readout11dTrial primary completion: Clinical Study to Evaluate the Impact of the Accu-Chek SmartGuide CGM Solution on the Mean Change in Time in Range Compared With Self-Monitoring of Blood Glucose in Particip…

Sponsor: Hoffmann-La Roche. Status: Recruiting. Conditions: Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus. NCT06704672.

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readout11dPhase 2 primary completion: Dose-escalation of Regorafenib in Advanced Hepatocellular Carcinoma

Sponsor: Instituto do Cancer do Estado de São Paulo. Status: Active, not recruiting. Conditions: Liver Cancer, Hepatocellular Carcinoma. NCT05622136.

full page →ctgov ↗

RECRUITINGphase readout11dTrial primary completion: Effects of Vestibular-Oriented Balance Training Versus Motor Dual Task Training on Balance, Postural Control, and Fall Risk in Chronic Stroke Survivors

Sponsor: Ibadat International University, Islamabad. Status: Recruiting. Conditions: Chronic Stroke Patients. NCT07754747.

full page →ctgov ↗

Week of Nov 30, 2026

RECRUITINGphase readout26dPhase 2 primary completion: Corticosteroids for Post-Extubation Dysphagia

Sponsor: University of Colorado, Denver. Status: Recruiting. Conditions: Dysphagia, Laryngeal Edema. NCT06670521.

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readout26dTrial primary completion: Effects of a Black Rice Extract and Anthocyanidin Metabolites on the Synthesis and Release of BDNF in Healthy Subjects

Sponsor: University of California, Davis. Status: Active, not recruiting. Conditions: Cognition - Other, Depression, Anxiety. NCT06594848.

full page →ctgov ↗

NOT_YET_RECRUITINGphase readout26dTrial primary completion: Developing and Strengthening Cannabis Warnings: Warning Message Testing

Sponsor: University of North Carolina, Chapel Hill. Status: Not yet recruiting. Conditions: Cannabis, Marijuana Use. NCT07699198.

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readout26dTrial primary completion: A Study of Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) for Insomnia During Pregnancy

Sponsor: Xijing Hospital. Status: Active, not recruiting. Conditions: Insomnia. NCT07730762.

full page →ctgov ↗

RECRUITINGphase readout26dPhase 1 primary completion: Phase I/Ib Study of NK Expressing an Affinity-enhanced T-cell Receptor (TCR) Against the NY-ESO-1

Sponsor: M.D. Anderson Cancer Center. Status: Recruiting. Conditions: Synovial Sarcoma, Myxoid/Round Cell Liposarcoma. NCT06083883.

full page →ctgov ↗

RECRUITINGphase readout26dTrial primary completion: The Puerto Rico Asthma Integrated Response Program ("PR-AIR")

Sponsor: Rhode Island Hospital. Status: Recruiting. Conditions: Pediatric Asthma. NCT05999032.

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readout26dPhase 1 primary completion: Study of RP3 Monotherapy and RP3 in Combination With Nivolumab in Patients With Solid Tumours

Sponsor: Replimune, Inc.. Status: Active, not recruiting. Conditions: Advanced Solid Tumor. NCT04735978.

full page →ctgov ↗

NOT_YET_RECRUITINGphase readout26dTrial primary completion: The Effect of Individual Sodium Citrate Consumption on Repeated Sprint Performance in Female Soccer Players

Sponsor: Hacettepe University. Status: Not yet recruiting. Conditions: Exercise-Induced Fatigue, Athletic Performance, Soccer. NCT07737327.

full page →ctgov ↗

RECRUITINGphase readout26dTrial primary completion: Effects of Pork Protein on Recovery Following Simulated Fireground Activity

Sponsor: Sam Houston State University. Status: Recruiting. Conditions: Exercise Recovery, Physical Performance Parameters, Muscle Damage, Cognition. NCT07819565.

full page →ctgov ↗

NOT_YET_RECRUITINGphase readout26dTrial primary completion: Ultrasonographic ONSD as a Predictor of PDPH in Spinal Anesthesia for Cesarean Delivery

Sponsor: Al-Azhar University. Status: Not yet recruiting. Conditions: Cesarean Section Complications. NCT07360756.

full page →ctgov ↗

RECRUITINGphase readout26dTrial primary completion: Transauricular Vagus Nerve Stimulation Frequencies for Postoperative Pain

Sponsor: Federal University of Bahia. Status: Recruiting. Conditions: Postoperative Pain, Postoperative Nausea and Vomiting (PONV), Opioid Consumption, Postoperative. NCT07633444.

full page →ctgov ↗

RECRUITINGphase readout26dTrial primary completion: Oral Health and Systemic Diseases: Survey of General Practitioners

Sponsor: University of Roma La Sapienza. Status: Recruiting. Conditions: Periodontal Disease, Diabete Mellitus. NCT07604493.

full page →ctgov ↗

WITHDRAWNphase readout26dTrial primary completion: Prevalence Study and Identification of Factors Prognosis of Obstructive Sleep Apnea Syndrome Sleep in Pregnant Women

Sponsor: GCS Ramsay Santé pour l'Enseignement et la Recherche. Status: Withdrawn. Conditions: Pregnancy Related. NCT05725642.

full page →ctgov ↗

RECRUITINGphase readout26dPhase 4 primary completion: Post-discharge Malaria Chemoprevention Implementation Trial in Benin

Sponsor: Institut de Recherche Clinique du Benin. Status: Recruiting. Conditions: Severe Malaria, Severe Anaemia. NCT06601712.

full page →ctgov ↗

RECRUITINGphase readout26dTrial primary completion: Generative AI Plan for Care Lab Study

Sponsor: Fitbit LLC. Status: Recruiting. Conditions: Primary Health Care. NCT07552311.

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readout26dPhase 3 primary completion: Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents

Sponsor: Dana-Farber Cancer Institute. Status: Active, not recruiting. Conditions: Acute Lymphoblastic Leukemia, Pediatric. NCT03020030.

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readout26dTrial primary completion: Clinical Fit of Conventionally Cast and 0° SLM Removable Partial Denture Frameworks

Sponsor: IBB University. Status: Active, not recruiting. Conditions: Partial Edentulism Class 3, Removable Partial Denture. NCT07863427.

full page →ctgov ↗

RECRUITINGphase readout26dTrial primary completion: Repeatable Evaluation of Functional Intra-procedural Signals for Effect in Pulsed Field Ablation REFINE-PFA

Sponsor: CathVision ApS. Status: Recruiting. Conditions: Atrial Fibrillation. NCT07275151.

full page →ctgov ↗

NOT_YET_RECRUITINGphase readout26dTrial primary completion: Effect of Loss-of-Resistance Syringe Training on Endotracheal Tube Cuff Pressure

Sponsor: Yusuf YILMAZ. Status: Not yet recruiting. Conditions: Endotracheal Tube Cuff Pressure, Postoperative Sore Throat. NCT07844486.

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readout26dTrial primary completion: Exercise and Mindfulness Intervention for Chemotherapy-Induced Peripheral Neuropathy in Patients With Cancer

Sponsor: Nanjing Medical University. Status: Active, not recruiting. Conditions: Cancer Patients, Chemotherapy-Induced Peripheral Neuropathy, Exercise Intervention. NCT07556965.

full page →ctgov ↗

NOT_YET_RECRUITINGphase readout26dTrial primary completion: Pilot Study of a Modified Therapeutic Food Compared With a Standard Nutrient Supplement in Young Children in Rural Guatemala

Sponsor: Wuqu' Kawoq, Maya Health Alliance. Status: Not yet recruiting. Conditions: Stunting of Growth, Chronic Malnutrition. NCT07804667.

full page →ctgov ↗

RECRUITINGphase readout26dPhase 2 primary completion: SBRT + PD-1 Antibody in Unresectable Locally Recurrent Rectal Cancer（SPARKLE）

Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University. Status: Recruiting. Conditions: Unresectable Locally Recurrent Rectal Cancer. NCT06767007.

full page →ctgov ↗

ENROLLING_BY_INVITATIONphase readout26dTrial primary completion: A Registry Based Collaborative to Measure Efficiency, Effectiveness, and Safety of Farapulse PFA Technology for AF

Sponsor: Heart Rhythm Clinical and Research Solutions, LLC. Status: Enrolling by invitation. Conditions: Atrial Fibrillation. NCT06335082.

full page →ctgov ↗

RECRUITINGphase readout26dTrial primary completion: Evaluation of the Administration of Artificial Nutrition by Feeding Jejunostomy During Neoadjuvant Treatment on Postoperative Morbidity in the Context of Esophageal or Stoma…

Sponsor: University Hospital, Bordeaux. Status: Recruiting. Conditions: Esophageal Cancer, Surgery Indication, Malnourished, Neoadjuvant Treatment. NCT07584577.

full page →ctgov ↗

RECRUITINGphase readout26dTrial primary completion: Dry Needling and Low-Level Laser Microcurrent Electrical Stimulation for Myofascial Pain Syndrome

Sponsor: Udayana University. Status: Recruiting. Conditions: Myofacial Pain Syndrome. NCT07750392.

full page →ctgov ↗

Dec 2026phase readout27dTrial primary completion: Evaluation of Sympathetic Activity Effects by the BackBeat Medical Cardiac Neuromodulation Therapy (CNT).

Sponsor: BackBeat Medical Inc. Status: Active, not recruiting. Conditions: Hypertension. NCT05462405.

full page →ctgov ↗

Dec 2026phase readout27dTrial primary completion: Implementation of Tobacco Cessation Programming at Community Behavioral Health Sites

Sponsor: University of Chicago. Status: Recruiting. Conditions: Nicotine Use Disorder, Smoking Cessation, Smoking Cessation Intervention. NCT06837220.

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readout27dTrial primary completion: The Clinical Application Study of Obinutuzumab in Pediatric Refractory Nephrotic Syndrome

Sponsor: Children's Hospital of Chongqing Medical University. Status: Active, not recruiting. Conditions: Primary Nephrotic Syndrome. NCT07612592.

full page →ctgov ↗

Dec 2026phase readout27dPhase 2 primary completion: Safety and Efficacy of TollB-001 Tablets in Moderate to Severe Rheumatoid Arthritis

Sponsor: Toll Biotech Co. Ltd. (Beijing). Status: Recruiting. Conditions: Rheumatoid Arthritis (RA). NCT07408024.

full page →ctgov ↗

calendar

Week of Nov 2, 2026

Week of Nov 9, 2026

Week of Nov 16, 2026

Week of Nov 23, 2026

Week of Nov 30, 2026